Skip to main content
Log in

FK506 and the role of immunophilins in nerve regeneration

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

FK506 is a new FDA-approved immunosuppressant used for prevention of allograft rejection in, for example, liver and kidney transplantations. FK506 is inactive by itself and requires binding to an FK506 binding protein-12 (FKBP-12), or immunophilin, for activation. In this regard, FK506 is analogous to cyclosporin A, which must bind to its immunophilin (cyclophilin A) to display activity. This FK506-FKBP complex inhibits the activity of the serine/threonine protein phosphatase 2B (calcineurin), the basis for the immunosuppressant action of FK506. The discovery that immunophilins are also present in the nervous system introduces a new level of complexity in the regulation of neuronal function. Two important calcineurin targets in brain are the growth-associated protein GAP-43 and nitric oxide (NO) synthase (NOS).

This review focuses on studies showing that systemic administration of FK506 dose-dependently speeds nerve regeneration and functional recovery in rats following a sciatic-nerve crush injury. The effect appears to result from an increased rate of axonal regeneration. The nerve regenerative property of this class of agents is separate from their immunosuppressant action because FK506-related compounds that bind to FKBP-12 but do not inhibit calcineurin are also able to increase nerve regeneration. Thus, FK506's ability to increase nerve regeneration arises via a calcineurin-independent mechanism (i.e., one not involving an increase in GAP-43 phosphorylation). Possible mechanisms of action are discussed in relation to known actions of FKBPs: the interaction of FKBP-12 with two Ca2+ release-channels (the ryanodine and inositol 1,4,5-triphosphate receptors) which is disrupted by FK506, thereby increasing Ca2+ flux; the type 1 receptor for the transforming growth factor-β (TGF-β1), which stimulates nerve growth factor (NGF) synthesis by glial cells, and is a natural ligand for FKBP-12; and the immunophilin FKBP-52/FKBP-59, which has also been identified as a heat-shock protein (HSP-56) and is a component of the nontransformed glucocorticoid receptor.

Taken together, studies of FK506 indicate broad functional roles for the immunophilins in the nervous system. Both calcineurin-dependent (e.g., neuroprotection via reduced NO formation) and calcineurin-independent mechanisms (i.e., nerve regeneration) need to be invoked to explain the many different neuronal effects of FK506. This suggests that multiple immunophilins mediate FK506's neuronal effects. Novel, nonimmunosuppressant ligands for FKBPs may represent important new drugs for the treatment of a variety of neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abe K., Chu P.-J., Ishihara A., and Saito H. (1996) Transforming growth factor-β1 promotes reelongation of injured axons of cultured rat hippocampal neurons.Brain Res. 723, 206–209.

    PubMed  CAS  Google Scholar 

  • Alnemri E. S., Fernandes-Alnemri T., Nelki D. S., Dudley K., DuBois G. C., and Litwack G. (1993) Overexpression, characterization, and purification of a recombinant mouse immunophilin FKBP-52 and identification of an associated phosphoprotein.Proc. Natl. Acad. Sci. USA 90, 6839–6843.

    PubMed  CAS  Google Scholar 

  • Angelov D. N., Neiss V. F., Streppel M., Andermahr J., Mader K., and Stennert E. (1996) Nimodipine accelerates axonal sprouting after surgical repair of rat facial nerve.J. Neurosci. 16, 1041–1048.

    PubMed  CAS  Google Scholar 

  • Armistead D. M., Badia M. C., Deininger D. D., Duffy J. P., Saunders J. O., Tung R. D., Thomson J. A., DeCenzo M. T., Futer O., Livingston D. J., Murcko M. A., Yamashita M. M., and Navia M. A. (1995) Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506.Acta Cryst. 51, 522–528.

    CAS  Google Scholar 

  • Bächinger H. P., Morris N. P., and Davis J. M. (1993) Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.Am. J. Med. Genet. 45, 152–162.

    PubMed  Google Scholar 

  • Banker G. A. and Cowan W. M. (1977) Rat hippocampal neurons in dispersed cell culture.Brain Res. 126, 397–425.

    PubMed  CAS  Google Scholar 

  • Batchelor M. J., Gillespie R. J., Golec J. M. C., Hedgecock C. J. R., Jones S. D., and Murdoch R. (1994) Total synthesis of close analogues of the immunosuppressant FK506.Tetrahedron 50, 809–825.

    CAS  Google Scholar 

  • Baughman G., Wiederrecht G. J., Campbell N. F., Martin M. M., and Bourgeois S. (1995) FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.Mol. Cell Biol. 15, 4395–4402.

    PubMed  CAS  Google Scholar 

  • Bennett P. C., Zhao W., Lawen A., and Ng K. T. (1996) Cyclosporin A, an inhibitor of calcineurin, impairs memory formation in day-old chicks.Brain Res. 730, 107–117.

    PubMed  CAS  Google Scholar 

  • Beuche W. and Friede R. L. (1984) The role of non-resident cells in Wallerian degeneration.J. Neurocytol. 13, 767–796.

    PubMed  CAS  Google Scholar 

  • Bierer B. E., Somers P. K., Wandless T. J., Burakoff S. J., and Schreiber S. L. (1990) Probing immunosuppressant action with a nonnatural immunophilin ligand.Science 250, 556–559.

    PubMed  CAS  Google Scholar 

  • Bijlsma W. A., Jennekens W. A., Schotman P., and Gispen W. H. (1984) Neurotrophic factors and regeneration in the peripheral nervous system.Psychoneuroendocrinology 9, 199–215.

    PubMed  CAS  Google Scholar 

  • Bijlsma W. A., Jennekens F. G. I., Schotman P., and Gispen W. H. (1983) Stimulation of ACTH4-10 of nerve fiber regeneration following sciatic nerve crush.Muscle Nerve 6, 104–112.

    PubMed  CAS  Google Scholar 

  • Bijlsma W. A., Jennekens F. G. I., Schotman P., and Gispen W. H. (1981) Effects of corticotrophin (ACTH) on recovery of sensorimotor function in the rat: structure-activity study.Eur. J. Pharmacol. 76, 73–79.

    PubMed  CAS  Google Scholar 

  • Bixby J. L. and Jhabvala P. (1993) Tyrosine phosphorylation in early embryonic growth cones.J. Neurosci. 13, 3421–3432.

    PubMed  CAS  Google Scholar 

  • Brück W. and Friede R. L. (1990) Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophagesin vitro.Acta Neuropath. 103, 182–187.

    Google Scholar 

  • Brillantes A. M. B., Ondrias K., Scott A., Kobrinsky E., Ondriasova E., Moschella M. C., Jayaraman T., Landers M., Ehrlich B. E., and Marks A. R. (1994) Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein.Cell 77, 513–523.

    PubMed  CAS  Google Scholar 

  • Bronster D. J., Yonover P., Stein J., Scelsa S. N., Miller C. M., and Sheiner P. A. (1995) Demyelinating sensorimotor polyneuropathy after administration of FK506.Transplantation 59, 1066–1068.

    PubMed  CAS  Google Scholar 

  • Butcher S. P., Henshall D. C., Teramura Y., Iwasaki K., and Sharkey J. (1997) Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an anti-excitotoxic mechanism.J. Neurosci. 17, 6939–6946.

    PubMed  CAS  Google Scholar 

  • Cameron A. M., Steiner J. P., Sabatini D. M., Kaplin A. I., Walensky L. D., and Snyder S. H. (1995a) Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux.Proc. Natl. Acad. Sci. USA 92, 1784–1788.

    PubMed  CAS  Google Scholar 

  • Cameron A. M., Steiner J. P., Roskams A. J., Ali S. M., Ronnett G. V., and Snyder S. H. (1995b) Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux.Cell 83, 463–472.

    PubMed  CAS  Google Scholar 

  • Cardenas M. E., Zhu D., and Heitman J. (1995) Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.Curr. Opin. Nephrol. Hypertens. 4, 472–477.

    PubMed  CAS  Google Scholar 

  • Chang H. Y., Takei K., Sydor A. M., Born T., Rusnak F., and Jay D. G., (1995) Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin.Nature 376, 686–690.

    PubMed  CAS  Google Scholar 

  • Charng M.-J., Kinnunen P., Hawker J., Brand T., and Schneider M. D. (1996) FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-β receptors.J. Biol. Chem. 271, 22941–22944.

    PubMed  CAS  Google Scholar 

  • Chen S. and Bisby M. A. (1993) Impaired motor axon regeneration in the C57BL/Ola mouse.J. Comp. Neurol. 333, 449–454.

    PubMed  CAS  Google Scholar 

  • Compton L. A., Davis J. M., MacDonald J. R., and Bächinger H. P. (1992) Structural and function characterization ofEscherichia coli peptidyl-prolylcis-trans isomerases.Eur. J. Biochem. 206, 927–934.

    PubMed  CAS  Google Scholar 

  • Contreras P. C., Steffler C., Yu E., Callison K., Stong D., and Vaught J. L. (1995) Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice.J. Pharmacol. Exp. Ther. 274, 1443–1449.

    PubMed  CAS  Google Scholar 

  • Cosenza C. A., Cramer D. V., and Makowka L. (1994) The use of immunosuppressive agents in animal models of experimental transplantation, inHandbook of Animal Models in Transplantation Research (Cramer D. V., Posesta L., and Makowka L. (eds.), CRC Press, Boca Raton, FL, pp. 331–337.

    Google Scholar 

  • Czar M. J., Owens-Grillo J. K., Yem A. W., Leach K. L., Deibel M. R., Jr., Welsh M. J., and Pratt W. B. (1994) The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor.Mol. Endocrin. 8, 1731–1741.

    CAS  Google Scholar 

  • Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R., and Snyder S. H. (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.Proc. Natl. Acad. Sci. USA 90, 9808–9812.

    PubMed  CAS  Google Scholar 

  • De Koning P. and Gispen W. H. (1987a) A rationale for the use of melanocortins in neural damage, inPharmacological Approaches to the Treatment of Brain and Spinal Cord Injury (Stein D. G. and Sabel G., eds.) Plenum, New York, pp. 233–258.

    Google Scholar 

  • De Koning P. and Gispen W. H. (1987b) Org. 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat.Peptides 8, 415–422.

    PubMed  Google Scholar 

  • Diamond J., Foerster A., Holmes M., and Coughlin M. (1992) Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF.J. Neurosci. 12, 1467–1476.

    PubMed  CAS  Google Scholar 

  • Drake M., Friberg H., Boris-Möller F., Sakata K., and Wieloch T. (1996) The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain.Acta Physiol. Scand. 158, 155–159.

    PubMed  CAS  Google Scholar 

  • Dumont F. J., Staruch M. J., Koprak S. L., Siekierka J. J., Lin C. S., Harrison R., Sewell T., Kindt V. M., Beattie T. R., Wyvratt M., and Sigal N. H. (1992) The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.J. Exp. Med. 176, 751–760.

    PubMed  CAS  Google Scholar 

  • Edwards P. M., Verhaagen J., Spierings T., Schotman P., Jennekens F. G. I., and Gispen W. H. (1985) The effect of ACTH4–10 on protein synthesis, actin and tubulin during regeneration.Brain Res. Bull. 15, 267–272.

    PubMed  CAS  Google Scholar 

  • Ekström P. A. R. and Tomlinson D. R. (1990) Impaired nerve regeneration in streptozotocin-diabetic rats is improved by treatment with gangliosides.Exp. Neurol. 109, 200–203.

    PubMed  Google Scholar 

  • Ekström P. A. R., Kanje M., and Skottner A. (1989) Nerve regeneration and serum levels of insulin-like growth factor-I in rats with streptozotocin-induced insulin deficiency.Brain Res. 496, 141–147.

    PubMed  Google Scholar 

  • Figueras A., Morales-Olivas F. J., and Capella D. (1992) Bovine gangliosides and acute motor polyneuropathy.Brit. Med. J. 305, 1330–1331.

    PubMed  CAS  Google Scholar 

  • Freman D. A., Klee C. B., Bierer B. E., and Burakoff S. J. (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A.Proc. Natl. Acad. Sci. USA 89, 3686–3690.

    Google Scholar 

  • Friede R. L. and Brück W. (1993) Macrophage functional properties during myelin degradation.Adv. Neurol. 59, 327–336.

    PubMed  CAS  Google Scholar 

  • Funauchi M., Haruta H., and Tsumoto T. (1994) Effects of an inhibitor for calcium/calmodulin-dependent protein phosphatase, calcineurin, on induction of long-term potentiation in rat visual cortex.Neurosci. Res. 19, 269–278.

    PubMed  CAS  Google Scholar 

  • Fung J. J., Eliasziw M., Todo S., Jain A., Demetris A. J., McMichael J. P., Starzl T. E., Meier P., and Donner A. (1996) The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.J. Am. Coll. Surg. 183, 117–125.

    PubMed  CAS  Google Scholar 

  • Gallai V., Mazzotta G., Montesi S., Sarchielli P., and Del Gatto F. (1992) Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study.Acta Neurol. Scand. 86, 3–7.

    PubMed  CAS  Google Scholar 

  • Giannini G., Conti A., Mammarella S., Scrobogna M., and Sorrentino V. (1995) The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.J. Cell Biol. 128, 893–904.

    PubMed  CAS  Google Scholar 

  • Gispen W. H., Sporel-Özakat E., Duckers E., and Edwards P. M. (1991) The Ca2+ antagonist nimodipine and recovery of function following peripheral nerve damage in the rat.Neurosci. Res. Commun. 8, 175–184.

    CAS  Google Scholar 

  • Gold B. G. (1997) Axonal regeneration of sensory neurons is delayed by continous intrathecal infusion of nerve growth factor.Neuroscience 76, 1153–1158.

    PubMed  CAS  Google Scholar 

  • Gold B. G., Zeleny-Pooley M., Wang M.-S., Chaturvedi P., and Armistead D. M. (1997) A non-immunosuppressant FKBP-12 ligand increases nerve regeneration.Exp. Neurol. 147, 269–278.

    PubMed  CAS  Google Scholar 

  • Gold B. G., Katoh K., and Storm-Dickerson T. (1995) The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve.J. Neurosci. 15, 7505–7516.

    Google Scholar 

  • Gold B. G., Storm-Dickerson T., and Austin D. R. (1994) The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury.Restor. Neurol. Neurosci. 6, 287–296.

    CAS  Google Scholar 

  • Gold B. G., Storm-Dickerson T., Austin D. R., and Katoh K. (1993) FK506, an immunosuppressant, increases functional recovery and axonal regeneration in the rat following axotomy of the sciatic nerve.Soc. Neurosci. Abstr. 19, 1316.

    Google Scholar 

  • Goldberger M. M., Murray M., and Tessler A. (1993) Sprouting and regeneration in the spinal cord: Their roles in recovery of function after spinal injury, inNeuroregeneration (Gorio A., ed.), Raven, New York, pp. 241–264.

    Google Scholar 

  • Gorio A., DiGiulio A. M., and Mantegazza P. (1993) Pharmacology of neuronal regeneration, inNeuroregeneration (Gorio A., ed.), Raven, New York, pp. 289–320.

    Google Scholar 

  • Goto S. and Singer W. (1994) Laminar and columnar organization of immunoreactivity for calcineurin, a calcium- and calmodulin-regulated protein phosphatase, in monkey striate cortex.Cereb. Cortex 4, 636–645.

    PubMed  CAS  Google Scholar 

  • Griffin J. W., George R., and Ho T. (1993) Macrophage systems in peripheral nerves: a review.J. Neuropathol. Exp. Neurol. 52, 553–560.

    PubMed  CAS  Google Scholar 

  • Griffith J. P., Kim J. L., Kim E. E., Sintchank M. D., Thomson J. A., Fitzgibbon M. J., Fleming M. A., Caron P. R., Hsiao K., and Navia M. A. (1995) X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex.Cell 82, 507–522.

    PubMed  CAS  Google Scholar 

  • Harding M. W., Galat A., Uehling D. E., and Schreiber S. L. (1989) A receptor for the immunosuppressant FK506 is acis-trans peptidyl-prolyl isomerase.Nature 341, 758–760.

    PubMed  CAS  Google Scholar 

  • Hindley S., Juurlink B. H. J., Gusbers J. W., Middlemiss P. J., Herman M. A. R., and Rothbone M. P. (1997) Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism.J. Neurosci. Res. 47, 427–439.

    PubMed  CAS  Google Scholar 

  • Hodgkiss J. P. and Kelly J. S. (1995) Only “de novo” long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex.Brain Res. 705, 241–246.

    PubMed  CAS  Google Scholar 

  • Hoffman A. L., Makowka L., Banner B., Cai X., Cramer D. V., Pascualone A., Todo S., and Starzl T. E. (1990) The use of FK-506 for small intestine allotransplantation: inhibition of acute rejection and prevention of fatal graft-versus-host disease.Transplantation 49, 483–490.

    PubMed  CAS  Google Scholar 

  • Hol E., Gispen W. H., and Bär P. R. (1995) ACTH-related peptides: Receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions.Peptides 16, 979–993.

    PubMed  CAS  Google Scholar 

  • Ide T., Morikawa E., and Kirino T. (1996) An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the Mongolian gerbil.Neurosci. Lett. 204, 157–160.

    PubMed  CAS  Google Scholar 

  • Ikegami S., Kato A., Kudo Y., Kuno T., Ozawa F., and Inokuchi K. (1996) A facilitatory effect on the induction of long-term potentiation in vivo by chronic administration of antisense oligodeoxynucleotides against catalytic subunits of calcineurin.Mol. Brain Res. 41, 183–191.

    PubMed  CAS  Google Scholar 

  • Itoh S., DeCenzo M. T., Livingston D. J., Pearlman D. A., and Navia M. A. (1995a) Conformation of FK506 in x-ray structures of its complexes with human recombinant FKBP12 mutants.Bioorganic Medicinal Chem. Lett. 5, 1983–1988.

    CAS  Google Scholar 

  • Itoh S. and Navia M. A. (1995b) Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).Protein Sci. 4, 2261–2268.

    PubMed  CAS  Google Scholar 

  • Jones K. J. (1993) Gonadal steroids as promoting factors in axonal regeneration.Brain Res. Bull. 30, 491–498.

    PubMed  CAS  Google Scholar 

  • Joosten E. A. J., Verhaagh S., Martin D., Robe P., Franzen R., Hooiveld M., Doornbos R., Bär P. R., and Moonen G. (1996) Alpha-MSH stimulates neurite outgrowth of neonatal rat corticospinal neuronsin vitro.Brain Res. 736, 91–98.

    PubMed  CAS  Google Scholar 

  • Kange M., Skottner A., Sjöberg J., and Lundborg G. (1989) Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve.Brain Res. 486, 396–398.

    Google Scholar 

  • Kantor D. B., Lanzrein M., Stary S. J., Sandoval G. M., Smith W. B., Sullivan B. M., Davidson N., and Schuman E. M. (1996) A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue.Science 274, 1744–1748.

    PubMed  CAS  Google Scholar 

  • Kino T. and Goto T. (1993) Discovery of FK-506 and update.Ann. NY Acad. Sci. 685, 13–21.

    PubMed  CAS  Google Scholar 

  • Kino T., Hatanaka H., Hashimoto M., and Nishiyama H. (1987a) FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physiochemical and biological characteristics.J. Antibiot. 40, 1249–1255.

    PubMed  CAS  Google Scholar 

  • Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H., and Ochiai T. (1987b) FK-506, a novel immunosuppressant isolated from a streptomyces. II. Immunosuppressive effect of FK-506 in vitro.J. Antibiot. 40, 1256–1265.

    PubMed  CAS  Google Scholar 

  • Kitamura Y., Itano Y., Kubo T., and Nomura Y. (1994) Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice.J. Neuroimmunol. 50, 221–224.

    PubMed  CAS  Google Scholar 

  • Klee C. B. (1991) Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin.Neurochem. Res. 16, 1059–1065.

    PubMed  CAS  Google Scholar 

  • Klintmalm G. (1994) The U.S. Multicenter FK 506 Liver Study Group: a comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.N. Engl. J. Med. 331, 1110–1115.

    Google Scholar 

  • Kralli A. and Yamamoto K. R. (1996) An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones.J. Biol. Chem. 271, 17152–17156.

    PubMed  CAS  Google Scholar 

  • Kuromi H., Yoshihara M., and Kidokoro Y. (1997) An inhibitory role of calcineurin in endocytosis of synaptic vesicles at nerve terminals ofDrosophila larvae.Neurosci. Res. 27, 101–113.

    PubMed  CAS  Google Scholar 

  • Ladner C. J., Czech J., Maurice J., Lorens S. A., and Lee J. M. (1996) Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes.J. Neuropathol. Exp. Neurol. 55, 924–931.

    PubMed  CAS  Google Scholar 

  • Landi G., D'Alessandro R. D., Dossi B. C., Ricci S., Simone I. L., and Ciccone A. (1993) Guillain-Barré syndrome after exogenous gangliosides in Italy.Brit. Med. J. 307, 1463–1464.

    PubMed  CAS  Google Scholar 

  • Lebeau M. C., Massol N., Herrick J., Faber L. E., Renoin M. J., Radanyi C., and Baulieu E. E. (1992) P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody.J. Biol. Chem. 267, 4281–4284.

    PubMed  CAS  Google Scholar 

  • Letteron P., Fouin-Fortunet H., Tinel M., Danan G., Belghiti J., and Pessayre D. (1984) Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.J. Pharmacol. Exp. Ther. 229, 845–850.

    PubMed  CAS  Google Scholar 

  • Lewin G. R. (1995) Neurotrophic factors and pain.Neuroscience 7, 227–232.

    Google Scholar 

  • Licitra E. J. and Liu J. O. (1996) A three-hybrid system for detecting small ligand-protein receptor interactions.Proc. Natl. Acad. Sci. USA 93, 12817–12821.

    PubMed  CAS  Google Scholar 

  • Lindholm D., Hengerer B., Zafra F., and Thoenen H. (1990) Transforming growth factor-β1 stimulates expression of nerve growth factor in the rat CNS.NeuroReport 1, 9–12.

    PubMed  CAS  Google Scholar 

  • Liu J., Farmer J. D., Lane W. S., Friedman J., Weissman I., and Schreiber S. L. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.Cell 66, 807–815.

    PubMed  CAS  Google Scholar 

  • Liu Y. and Storm D. R. (1990) Regulation of free calmodulin levels by neuromodulin: neuron growth and regeneration.Trends Pharmacol. Sci. 11, 107–111.

    PubMed  CAS  Google Scholar 

  • Lopez O. L., Martinez A. J., and Torre-Cisneros J. (1991) Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK506.Transplant. Proc. 23, 3181–3182.

    PubMed  CAS  Google Scholar 

  • Ludwin S. K. and Bisby M. A. (1992) Delayed Wallerian degeneration in the central nervous system of Ola mice: an ultrastructural study.J. Neurol. Sci. 109, 140–147.

    PubMed  CAS  Google Scholar 

  • Lyons W. E., Steiner J. P., Snyder S. H., and Dawson T. M. (1995) Neuronal regeneration enhances the expression of the immunophilin FKBP-12.J. Neurosci. 15, 2985–2994.

    PubMed  CAS  Google Scholar 

  • Lyons W. E., George E. B., Dawson T. M., Steiner J. P., and Snyder S. H. (1994) Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia.Proc. Natl. Acad. Sci. USA 91, 3191–3195.

    PubMed  CAS  Google Scholar 

  • Lyons W. E., Steiner J. P., Dawson T. M., and Snyder S. H. (1992) Increased expression of FK-506 binding protein during peripheral nerve regeneration.Soc. Neurosci. Abstr. 18, 604.

    Google Scholar 

  • Malen P. L. and Chapman P. F. (1997) Nitric oxide facilitates long-term potentiation, but not longterm depression.J. Neurosci. 17, 2645–2651.

    PubMed  CAS  Google Scholar 

  • Matsuura K., Kabuto H., Makino H., and Ogawa N. (1996) Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxy-dopamine in the mouse brain.J. Neuroimmunol. 733, 101–104.

    CAS  Google Scholar 

  • McDiarmid S. V., Busuttil R. W., Ascher N. L., Burdick A. J., D'Alessandro A. M., Esquivel C., Kalayoglu M., Klein A. S., Marsh J. W., Miller C. M., Schwartz M. E., Shaw B. W., and So S. K. (1995) FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation.Transplantation 59, 530–536.

    PubMed  CAS  Google Scholar 

  • Meiri K. F., Bickerstaff L. E., and Schwob J. E. (1991) Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo.J. Cell Biol. 112, 991–1005.

    PubMed  CAS  Google Scholar 

  • Moriwaki A., Lu Y.-F., Hayashi Y., Tomizawa K., Tokuda M., Itano T., Hatase O., and Matsui H. (1996) Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation.Neurosci. Res. 25, 191–194.

    PubMed  CAS  Google Scholar 

  • Mueller A. R., Platz K.-P., Bechstein W.-O., Schattenfroh N., Stoltenburg-Didinger G., Blumhardt G., Christe W., and Neuhaus P. (1994) Neurotoxicity after orthotopic liver transplantation. A comprison between cyclosporine and FK506.Transplantation 58 155–169.

    PubMed  CAS  Google Scholar 

  • Mukai H., Kuno T., Chang C.-D., Lane B., Luly J. R., and Tanaka C. (1993) FKBP12-FK506 complex inhibits phosphatase activity of two mammalian isoforms of calcineurin irrespective of their substrates or activation mechanisms.J. Biochem. 113, 292–298.

    PubMed  CAS  Google Scholar 

  • Murad F. (1990) Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers, and β-adrenergic antagonist, inGoodman and Gilman's: The Pharmacological Basis of Therapeutics (Gilman A. G., Rall T., Nies A. S., and Taylor P. eds.), Pergamon, New York, pp. 764–783.

    Google Scholar 

  • Murase N., Todo S., Lee P.-H., Chapman F., Nalesnik, M. A., Makowka L., and Starzl T. E. (1987) Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.Transplant. Proc. 19, 71–75.

    PubMed  CAS  Google Scholar 

  • Navia M. A. and Chaturvedi, P. R. (1996) Design principles for orally bioavailable drugs.DDT 1, 179–189.

    CAS  Google Scholar 

  • Neuhaus P., Pichlmayr R., and Williams R. (1994) The European FK 506 Multicentre Liver Study Group: randomised trial comparing tacrolimus (FK 506) and cyclosporin in prevention of liver allograft rejection.Lancet 344, 423–428.

    Google Scholar 

  • Nozaki H., Tanaka K., Gomi S., Mihara B., Nogawa S., Nagata E., Kondo T., and Fukuuchi Y. (1996) Alteration of ryanodine receptor in the hippocampus CA1 after hemispheric cerebral ischemia.Neurochem. Res. 21, 975–982.

    PubMed  CAS  Google Scholar 

  • O'Dell T. J., Hawkins R. D., Kandel E. R., and Arancio O. (1991) Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.Proc. Natl. Acad. Sci. USA 88, 11285–11289.

    PubMed  Google Scholar 

  • Ochiai T., Sakamoto K., Nagata M., Nakajima K., Goto T., Hori S., Kenmochi T., Nakagori T., Asano T., and Isono K. (1988) Studies on FK-506 in experimental organ transplantation.Transplant. Proc. 20, 209–214.

    PubMed  CAS  Google Scholar 

  • Ochiai T., Nakajima K., Nagata M., Suzuki T., Asano T., Uematsu T., Goto T., Hori S., Kenmochi T., Nakagoori T., and Isono K. (1987) Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.Transplant. Proc. 19, 1284–1286.

    PubMed  CAS  Google Scholar 

  • Odom A., Del Poeta M., Perfect J., and Heitman J. (1997) The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic toCryptococcus neoformans by inhibition of a common target protein.Antimicrob. Agents Chemother 41, 156–161.

    PubMed  CAS  Google Scholar 

  • Owens-Grillo J. K., Hoffmann K. Hutchison K. A., Yem A. W., Deibel M., R., Jr., Handschumacher R. E., and Pratt W. B. (1995) The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor.J. Biol. Chem. 270, 20479–2048.

    PubMed  CAS  Google Scholar 

  • Perdew G. H. and Whitelaw M. L. (1991) Evidence that the 90-kDa heat shock protein (HSP90) exists in cytosol in heteromeric complexes containing HSP70 and three other proteins with Mr of 63,000, 56,000, and 50,000.J. Biol. Chem. 266, 6708–6713.

    PubMed  CAS  Google Scholar 

  • Perry V. H., Brown M. C., Lunn E. R., Tree P., and Gordon S (1990a) Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve.,Eur. J. Neurosci. 2, 802–808.

    PubMed  Google Scholar 

  • Perry V. H., Lunn E. R., Brown M. C., Cahusac S., and Gordon S. (1990b) Evidence that the rate of Wallerian degeneration is controlled by a single autosomal dominant gene.Eur. J. Neurosci. 2, 408–413.

    PubMed  Google Scholar 

  • Ratajczak T. and Carrello A. (1996) Cyclophilin 40 (CyP-40), mapping of its hsp90 binding domain and evidence that FKBP52 competes with CyP-40 for hsp90 binding.J. Biol. Chem. 271, 2961–2965.

    PubMed  CAS  Google Scholar 

  • Roth G. A., Spada V., Hamill K., and Bornstein M. B. (1995) Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue.Dev. Brain Res. 88, 102–108.

    CAS  Google Scholar 

  • Sakai K., Date I., Yoshimoto Y., Arisawa T., Nakashima H., Furuta T., Asari S., and Ohmoto T. (1991) The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents.Brain Res. 565, 167–170.

    PubMed  CAS  Google Scholar 

  • Sanchez E. R. (1990) Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes.J. Biol. Chem. 265, 22067–22070.

    PubMed  CAS  Google Scholar 

  • Sánchez E. R. and Ning Y.-M. (1996) Immunophilins, heat shock protein, and glucocorticoid receptor actions in vivo.Meth. Enzymol. 9, 188–200.

    Google Scholar 

  • Schonhofer P. S. (1991) Guillain-Barré syndrome and parenteral gangliosides.Lancet 338, 757.

    Google Scholar 

  • Schreiber S. L. and Crabtree G. R. (1992) The mechanism of action of cyclosporin A and FK506.Immunol. Today 13, 136–142.

    PubMed  CAS  Google Scholar 

  • Schreiber S. L. (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands.Science 251, 283–287.

    PubMed  CAS  Google Scholar 

  • Schuman E. M. and Madison D. V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation.Science 254, 1503–1506.

    PubMed  CAS  Google Scholar 

  • Sebille A., Saint-André P., and Hugelin A. (1982) Acceleration by isaxonine of muscle reinnervation: electrophysiological demonstration in leprotic neuropathy.Nouv. Presse. Med. 11, 1278–1282.

    PubMed  CAS  Google Scholar 

  • Shapiro R., Fung J. J., Jain A. B., Parks P., Todo S., and Starzl T. E. (1990) The side effects of FK506 in humans.Tranplant. Proc. 22, 35–36.

    CAS  Google Scholar 

  • Sharkey J. and Butcher S. P. (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.Nature 371, 336–339.

    PubMed  CAS  Google Scholar 

  • Shibuki K. and Okada D. (1996) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum.Nature 349, 326–328.

    Google Scholar 

  • Shuker S. B., Hajduk P. J., Meadows R. P., and Fesik S. W. (1996) Discovering high-affinity ligands for proteins: SAR by NMR.Science 274, 1531–1534.

    PubMed  CAS  Google Scholar 

  • Siekierka J. J., Wiederrecht G., Greulich H., Boulton D., Hung S. H. Y., Cryan J., Hodges P. J., and Sigal N. H. (1990) The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolylcis-trans isomerase.J. Biol. Chem. 265, 21011–21015.

    PubMed  CAS  Google Scholar 

  • Siekierka J. J., Hung S. H. Y., Poe M., Lin C. S., and Sigal N. H. (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidylprolyl isomerase activity but is distinct from cyclophilin.Nature 341, 755–757.

    PubMed  CAS  Google Scholar 

  • Sigal N. H. and Dumont F. J. (1992) Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.Annu. Rev. Immunol. 10, 519–560.

    PubMed  CAS  Google Scholar 

  • Sigal N. H., Dumont F., Durette P., Siekierka J. J., Peterson L., Rich D. H., Dunlap B. E., Staruch M. J., Melino M. R., Koprak S. L., Williams D. Witzel B., and Pisano J. M. (1991) Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?J. Exp. Med. 173, 619–628.

    PubMed  CAS  Google Scholar 

  • Skene J. H. P. (1990) GAP-43 as a ‘calmodulin sponge’ and some implications for calcium signaling in axon terminals.Neurosci. Res. 13, S112-S125.

    CAS  Google Scholar 

  • Skene J. H. P. (1989) Axonal growth-associated proteins.Annu. Rev. Neurosci. 12, 127–156.

    PubMed  CAS  Google Scholar 

  • Skene J. H. P. and Willard M. B. (1981a) Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells.J. Cell Biol. 89, 86–95.

    PubMed  CAS  Google Scholar 

  • Skene J. H. P. and Willard M. B. (1981b) Axonally transported proteins associated with growth in rabbit central and peripheral nervous system.J. Cell Biol. 89, 96–103.

    PubMed  CAS  Google Scholar 

  • Snyder S. H. and Sabatini D. M. (1995) Immunophilins and the nervous system.Nature Medicine 1, 32–37.

    PubMed  CAS  Google Scholar 

  • Sporel-Özakat R. E., Edwards P. M., Gerritsen van der Hoop G., and Gispen W. H. (1990) An ACTH(4–9) analog, Org 2766, improves recovery from acrylamide neuropathy in rats.Eur. J. Pharmacol. 186, 181–187.

    PubMed  Google Scholar 

  • Starr R., Hall F. L., and Moneiro M. J. (1996) A cdc2-like kinase distinct from cdk5 is associated with neurofilaments.J. Cell Sci. 109, 1565–1573.

    PubMed  CAS  Google Scholar 

  • Starzl T. E., Todo S., Fung J., Demetris A. J., Venkataramman R., and Jain A. (1989) FK-506 for liver, kidney, and pancreas transplantation.Lancet 2, 1000–1004.

    PubMed  CAS  Google Scholar 

  • Starzl T. E., Makowka L., and Todo S. (1987) FK-506: a potential breakthrough in immunosuppression.Transplant. Proc. 19, S3-S104.

    Google Scholar 

  • Steiner J. P., Connolly M. A., Valentine H. L., Hamilton G. S., Dawson T. M., Hester L., and Snyder S. H. (1997a) Neurotrophic actions of nonimmunosuppressive ligands of immunophilins.Nature Med. 3, 1–8.

    Google Scholar 

  • Steiner J. P., Hamilton G. S., Ross D. T., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A. C., and Suzdak P. D. (1997b) Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.Proc. Natl. Acad. Sci. USA 94, 2019–2024.

    PubMed  CAS  Google Scholar 

  • Steiner J. P., Dawson T. M., Fotuhi M., and Snyder S. H. (1996) Immunophilin regulation of neurotransmitter release.Mol. Med. 96, 1076–1551.

    Google Scholar 

  • Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M. M., Cohen N., and Snyder S. H. (1992) High brain densities of the immunophilin FKBP colocalized with calcineurin.Nature 358, 584–587.

    PubMed  CAS  Google Scholar 

  • Steiner J. P., Dawson T. M., Fotuhi C., Glatt C., Snowman A. M., Cohen N., and Snyder S. H. (1991) The immunosuppressant FK-506 enhances phosphorylation of GAP43: implications for a role in modulation of growth cone function and neurotransmitter release.Soc. Neurosci. Abstr. 18, 603.

    Google Scholar 

  • Strand F. L. and Smith C. M. (1986) LPH, ACTH, MSH and motor systems, inNeuropeptides and Behavior (de Wied D., Gispen W. H. and van Wimersma Greidanus T. B., eds.), Pergamon, New York, pp. 245–272.

    Google Scholar 

  • Strand F. L. and Kung T. T. (1980) ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve.Peptides 1, 135–138.

    PubMed  CAS  Google Scholar 

  • Sugawara T., Itoh Y., Mori E., Kojima H., and Kowada M. (1995) Immunosuppressive agents enhance regeneration of adult dorsal root axons into spinal cord.Soc. Neurosci. Abstr. 21, 315.

    Google Scholar 

  • Tai P.-K., Albers M. W., Chang H., Faber L. E., and Schreiber S. L. (1992) Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex.Science 256, 1315–1318.

    PubMed  CAS  Google Scholar 

  • Takei K., Jay D. G., and Mikoshiba K. (1996) Regional laser inactivation of type 1 inositol 1,4,5 trisphosphate receptor affects growth cone morphology and motility in chick DRG neurons.Soc. Neurosci. Abstr. 22, 740.

    Google Scholar 

  • Taniuchi M., Clark H. B., Schweitzer J. B., and Johnson E. M., Jr. (1988) Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties.J. Neurosci. 8, 664–681.

    PubMed  CAS  Google Scholar 

  • Terada N., Or R., Weinberg K., Domenico J., Lucas J. J., and Gelfand E. W. (1992) Transcription of IL-4 genes is not inhibited by cyclosporin A in competent T cells.J. Biol. Chem. 267, 21,207–21,210.

    CAS  Google Scholar 

  • Timerman A. P., Ogunbumni E., Freund E., Wiederrecht G., Marks A. R., and Fleischer S. (1993) The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein.J. Biol. Chem. 268, 22,992–22,999.

    CAS  Google Scholar 

  • Tocci M. J., Matkovich D. A., Matkovich K., Collier K. A., Kwok P., Dumont F., Lin S., Degudicibus S., Siekerka J. J., Chin J., and Hutchinson N. I. (1989) The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.J. Immunol. 143, 718–726.

    PubMed  CAS  Google Scholar 

  • Todo S., Demetris A., Ueda Y., Imventarza O., Cadoff E., Zeevi A., and Starzl T. E. (1989) Renal transplantation in baboons under FK 506.Surgery 106, 444–451.

    PubMed  CAS  Google Scholar 

  • Todo S., Ueda Y., Demetris J. A., Imventarza O., Nalesnik M., Venkataramman R., Makowka L., and Starzl T. E. (1988) Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.Surgery 104, 239–249.

    PubMed  CAS  Google Scholar 

  • Todo S., Podesta L., ChapChap P., Kahn D., Pan E.-E., Ueda Y., Ukuda K., Imventarza O., Casavilla A., Demetris A. J., Makowka L., and Starzl T. E. (1987) Orthotopic liver transplantation in dogs receiving FK-506.Transplant. Proc. 19, S64-S67.

    Google Scholar 

  • Tokime T., Nozaki K., and Kikuchi H. (1996) Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil.Neurosci. Lett. 206, 81–84.

    PubMed  CAS  Google Scholar 

  • Tong G., Shepherd D., and Jahr C. E. (1995) Synaptic desensitization of NMDA receptors by calcineurin.Science 267, 1510–1512.

    PubMed  CAS  Google Scholar 

  • Torii N., Kamishita T., Otsu Y., and Tsumoto T. (1995) An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex.Neuroscience 185, 1–4.

    CAS  Google Scholar 

  • Vincenti F., Laskow D. A., Neylan J. F., Mendez R., and Matas A. J. (1996) One-year follow-up of an open-label trial of FK506 for primary kid-ney transplantation.Transplantation 61, 1576–1581.

    PubMed  CAS  Google Scholar 

  • Walsh C. T., Zydowsky L. D., and McKeon F. D., (1992) Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction.J. Biol. Chem. 267, 13,115–13,118.

    CAS  Google Scholar 

  • Wang M. S., Zeleny-Pooley M., and Gold B. G. (1997) Comparative dose-dependency study of FK506 and cyclosporin A on the rate of axonal regeneration in rat sciatic nerve.J. Pharmacol. Exp. Ther. 282, 1084–1093.

    PubMed  CAS  Google Scholar 

  • Wang T., Li B.-y., Danielson P. D., Rockwell S., Lechleider R. J., Martin J., Manganaro T., and Donahoe P. K. (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors.Cell 86, 435–444.

    PubMed  CAS  Google Scholar 

  • Wang T., Donahoe P. K., and Zervos A. S. (1994) Specific interaction of type I receptors of the TGFβ family with the immunophilin FKBP-12.Science 265, 674–676.

    PubMed  CAS  Google Scholar 

  • Wayne D. B. and Skene J. H. P. (1995) Endogenous nitric oxide modulates neurite growth in regenerating rat sensory neurons.Soc. Neurosci. Abstr. 21, 1292.

    Google Scholar 

  • Wiederrect G. and Etzkorn F. (1995) The immunophilins.Perspectives Drug Discovery Design 2, 57–84.

    Google Scholar 

  • Wiederrecht G., Lam E., Hung S., Martin M., and Sigal N. (1993) The mechanism of action of FK-506 and cyclosporin A.Ann. NY Acad. Sci. 696, 9–19.

    PubMed  CAS  Google Scholar 

  • Wiederrecht G., Hung S., Chan H. K., Marcy A., Martin M., Calaycay J., Boulton D., Sigal N., Kincaid R. L., and Siekierka J. J. (1992) Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex.J. Biol. Chem. 267, 21,753–21,760.

    CAS  Google Scholar 

  • Wijdicks E. F. M., Weisner R. H., Dahlke L. J., and Krom R. A. F. (1994) FK506-induced neurotoxicity in liver transplantation.Ann. Neurol. 35, 498–501.

    PubMed  CAS  Google Scholar 

  • Yagita Y., Kitagawa K., Matsushita K., Taguchi A., Mabuchi T., Ohtsuki T., Yanagihara T., and Matsumoto M. (1996) Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils.Life Sci. 59, 1643–1650.

    PubMed  CAS  Google Scholar 

  • Yao G. L. and Kiyama H. (1995) Dexamethasone enhances level of GAP-43 mRNA after nerve injury and facilitates re-projection of the hypoglossal nerve.Mol. Brain Res. 32, 308–312.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gold, B.G. FK506 and the role of immunophilins in nerve regeneration. Mol Neurobiol 15, 285–306 (1997). https://doi.org/10.1007/BF02740664

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02740664

Index Entries

Navigation